A study into the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor antagonists Vrije Universiteit Brussel
Background and purpose. CCR5 is a coreceptor for HIV-1 infection and target for anti-viral therapy. A greater understanding of the binding kinetics of small molecule allosteric ligand interaction with CCR5 will lead to a better understanding of the binding process and may help discover new molecules that avoid resistance.
Experimental approach. Using [3H] maraviroc as a radioligand, a number of different binding protocols were employed in ...
Experimental approach. Using [3H] maraviroc as a radioligand, a number of different binding protocols were employed in ...